Current Signal Transduction Therapy
Title:EDITORIAL: Novel Signaling Pathway Based Therapeutics in Cancer and Other Diseases
Volume: 12 Issue: 1
Author(s): Min Li*
Affiliation:
- Department of Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104,United States
Export Options
About this article
Cite this article as:
Li Min*, EDITORIAL: Novel Signaling Pathway Based Therapeutics in Cancer and Other Diseases, Current Signal Transduction Therapy 2017; 12 (1) . https://dx.doi.org/10.2174/157436241201170508200747
DOI https://dx.doi.org/10.2174/157436241201170508200747 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A New Approach for Skin-Derived Precursors to Ameliorate Skin Photodamage Through Activation of Nrf2 Signaling Pathway
Current Signal Transduction Therapy Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology Unmasking Sex-Based Disparity in Neuronal Metabolism
Current Pharmaceutical Design A New Approach of Delivering siRNA to the Cornea and its Application for Inhibiting Herpes Simplex Keratitis
Current Molecular Medicine Therapeutic Strategies Targeting Amyloid-β in Alzheimer’s Disease
Current Alzheimer Research Neuron Protection as a Therapeutic Target in Acute Ischemic Stroke
Current Topics in Medicinal Chemistry Renal Endothelial Dysfunction in Diabetic Nephropathy
Cardiovascular & Hematological Disorders-Drug Targets Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer’s Disease
Medicinal Chemistry Role of Free Radicals and Poly(ADP-Ribose)Polymerase-1 in the Development of Spinal Cord Injury: New Potential Therapeutic Targets
Current Medicinal Chemistry Transient Receptor Potential Vanilloid 1 Channel Modulation: A Novel Approach to Pain Therapy
Current Bioactive Compounds Systemic Delivery of siRNA: Challenging but Promising
Recent Patents on Drug Delivery & Formulation Oncologic Imaging End-Points for the Assessment of Therapy Response
Recent Patents on Anti-Cancer Drug Discovery The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Review of Pediatric Uveitis
Current Pediatric Reviews Promising Protective Effects of Chrysin in Cardiometabolic Diseases
Current Drug Targets Antioxidant Activities of Retinoidal Benzimidazole Or Indole Derivatives in In Vitro Model Systems
Current Medicinal Chemistry Adult Changes in Thought Study: Dementia is an Individually Varying Convergent Syndrome with Prevalent Clinically Silent Diseases that may be Modified by Some Commonly Used Therapeutics
Current Alzheimer Research NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Rodent Models of Ischemic Stroke: A Useful Tool for Stroke Drug Development
Current Pharmaceutical Design